Burning Rock Biotech Ltd (BNR) stock
BNRNasdaqServices-Medical Laboratories
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$12.50−0.24 (-1.88%)
Close on Nov 17, 2026Market cap $136.07MP/E –Yield –
Burning Rock Biotech EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2021 it was 0.00 CNY.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 0.00 CNY | – |
| FY2020 | Dec 31, 2020 | 0.00 CNY | – |
| FY2019 | Dec 31, 2019 | -14.23 CNY | – |
| FY2018 | Dec 31, 2018 | -10.38 CNY | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?